Inventor · disambiguated record
Robert B. Perni
Also filed as: PERNI ROBERT · PERNI ROBERT B
58 granted patents·50 pending applications·636 citations·filing 1993–2025
98Inventor score
Files withVERTEX PHARMA22ATAI THERAPEUTICS INC10TOTUS MEDICINES INC9ATAI Life Sciences AG7GLAXOSMITHKLINE LLC7
Top patents by PatentIndex Score
108 records- 0197US7208600B2Inhibitors of serine proteases, particularly HCV NS3-NS4A proteasesVERTEX PHARMA·Filed 2004·Granted Apr 24, 2007·129 cites·14 claims
- 0296US12065405B2Prodrugs and conjugates of dimethyltryptamineATAI THERAPEUTICS INC·Filed 2023·Granted Aug 20, 2024·4 cites·30 claims
- 0396US11643391B2Prodrugs and conjugates of dimethyltryptamineATAI Life Sciences AG·Filed 2022·Granted May 9, 2023·7 cites·8 claims
- 0495US7893086B2Sirtuin modulating compoundsSIRTRIS PHARMACEUTICALS INC·Filed 2008·Granted Feb 22, 2011·34 cites·23 claims
- 0595US7273885B2Inhibitors of serine proteases, particularly HCV NS3-NS4A proteaseVERTEX PHARMA·Filed 2003·Granted Sep 25, 2007·78 cites·29 claims
- 0694US12012381B2Dimethyltryptamine analogues as nitric oxide delivery drugsATAI THERAPEUTICS INC·Filed 2022·Granted Jun 18, 2024·4 cites·33 claims
- 0794US11912680B2Nitric oxide releasing prodrugs of MDA and MDMAATAI Life Sciences AG·Filed 2022·Granted Feb 27, 2024·3 cites·62 claims
- 0894US11827580B2Aminotetraline activators of serotonin receptorsATAI Life Sciences AG·Filed 2022·Granted Nov 28, 2023·4 cites·58 claims
- 0994US6909000B2Bridged bicyclic serine protease inhibitorsVERTEX PHARMA·Filed 2002·Granted Jun 21, 2005·78 cites·46 claims
- 1093US7820671B2Peptidomimetic protease inhibitorsVERTEX PHARMA·Filed 2001·Granted Oct 26, 2010·33 cites·8 claims
- 1192US7378422B2Inhibitors of serine proteases, particularly HCV NS3-NS4A proteaseVERTEX PHARMA·Filed 2004·Granted May 27, 2008·39 cites·14 claims
- 1292US7365092B2Inhibitors of serine proteases, particularly HCV NS3-NS4A proteaseVERTEX PHARMA·Filed 2004·Granted Apr 29, 2008·40 cites·50 claims
- 1392US7109172B2Inhibitors of serine proteases, particularly HCV NS3-NS4A proteaseVERTEX PHARMA·Filed 2004·Granted Sep 19, 2006·42 cites·13 claims
- 1491US11845736B2Prodrugs of MDMA, MDA, and derivatives thereofEMPATHBIO INC·Filed 2022·Granted Dec 19, 2023·2 cites·25 claims
- 1591US7241796B2Inhibitors of serine proteases, particularly HCV NS3-NS4A proteaseVERTEX PHARMA·Filed 2002·Granted Jul 10, 2007·40 cites·37 claims
- 1690US7906550B2Inhibitors of serine proteases, particularly HCV NS3-NS4A proteaseVERTEX PHARMA·Filed 2008·Granted Mar 15, 2011·7 cites·4 claims
- 1786US10316054B2Preparation and use of crystalline beta-D-nicotinamide ribosideGLAXOSMITHKLINE IP NO 2 LTD·Filed 2015·Granted Jun 11, 2019·6 cites·20 claims
- 1884US12351537B2Dimethoxyphenylalkylamine activators of serotonin receptorsATAI THERAPEUTICS INC·Filed 2024·Granted Jul 8, 2025·0 cites·11 claims
- 1984US9765075B2Substituted bridged urea analogs as sirtuin modulatorsGLAXOSMITHKLINE LLC·Filed 2014·Granted Sep 19, 2017·2 cites·4 claims
- 2084US8529882B2Peptidomimetic protease inhibitorsBABINE ROBERT EDWARD·Filed 2012·Granted Sep 10, 2013·3 cites·5 claims
- 2183US8039623B2Inhibitors of serine proteases, particularly HCV NS3-NS4A proteaseVERTEX PHARMA·Filed 2007·Granted Oct 18, 2011·5 cites·9 claims
- 2282US7494988B2Inhibitors of serine proteases, particularly hepatitis C virus NS3 proteaseVERTEX PHARMA·Filed 2003·Granted Feb 24, 2009·25 cites·22 claims
- 2381US11484597B2Therapeutic conjugatesTOTUS MEDICINES INC·Filed 2022·Granted Nov 1, 2022·1 cites·8 claims
- 2480US12454516B2Nitric oxide releasing prodrugs of MDA and MDMAEMPATHBIO INC·Filed 2024·Granted Oct 28, 2025·0 cites·62 claims
- 2580US12344570B2Aminotetraline activators of serotonin receptorsATAI THERAPEUTICS INC·Filed 2023·Granted Jul 1, 2025·0 cites·18 claims
- 2680US8685970B2Quinolines and related analogs as sirtuin modulatorsVU CHI B·Filed 2009·Granted Apr 1, 2014·7 cites·15 claims
- 2780US8618152B2Inhibitors of serine proteases, particularly HCV NS3-NS4A proteasesFARMER LUC J·Filed 2011·Granted Dec 31, 2013·2 cites·13 claims
- 2880US7745444B2Inhibitors of serine proteases, particularly HCV NS3-NS4A proteaseVERTEX PHARMA·Filed 2008·Granted Jun 29, 2010·3 cites·36 claims
- 2979US8343997B2Thiazolopyridine sirtuin modulating compoundsSIRTRIS PHARMACEUTICALS INC·Filed 2009·Granted Jan 1, 2013·3 cites·13 claims
- 3079US2025282712A1Dimethoxyphenylalkylamine activators of serotonin receptorsATAI THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 3176US9834558B2Substituted bridged urea analogs as sirtuin modulatorsGLAXOSMITHKLINE LLC·Filed 2014·Granted Dec 5, 2017·2 cites·2 claims
- 3276US2025026731A1Prodrugs of mdma, mda, and derivatives thereofEMPATHBIO INC·Filed 2024·Application pending·0 cites
- 3375US2025282708A1Aminotetraline activators of serotonin receptorsATAI THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 3473US10485814B2Nicotinamide riboside analogs and pharmaceutical compositions and uses thereofGLAXOSMITHKLINE IP NO 2 LTD·Filed 2015·Granted Nov 26, 2019·2 cites·18 claims
- 3573US8247532B2Deuterated hepatitis C protease inhibitorsPERNI ROBERT B·Filed 2010·Granted Aug 21, 2012·1 cites·20 claims
- 3673US2024366771A1Therapeutic conjugatesTOTUS MEDICINES INC·Filed 2024·Application pending·0 cites
- 3772US9326986B2Quinazolinone, quinolone and related analogs as sirtuin modulatorsVU CHI B·Filed 2009·Granted May 3, 2016·1 cites·16 claims
- 3872US8987258B2Chromenone analogs as sirtuin modulatorsOALMANN CHRISTOPHER·Filed 2009·Granted Mar 24, 2015·2 cites·4 claims
- 3972US8846947B2Benzimidazoles and related analogs as sirtuin modulatorsVU CHI B·Filed 2009·Granted Sep 30, 2014·1 cites·18 claims
- 4072US2023041584A1Novel prodrugs and conjugates of dimethyltryptamineATAI Life Sciences AG·Filed 2022·Application pending·0 cites
- 4171US8236815B2Ion channel modulators and methods of usesMARTINBOROUGH ESTHER·Filed 2010·Granted Aug 7, 2012·1 cites·11 claims
- 4270US12029791B2Therapeutic conjugatesTOTUS MEDICINES INC·Filed 2022·Granted Jul 9, 2024·0 cites·8 claims
- 4370US11591365B2BCL9 peptides and variants thereofWNTRX PHARMACEUTICALS INC·Filed 2018·Granted Feb 28, 2023·1 cites·11 claims
- 4470US2024317803A1Bcl9 peptides and variants thereofWNTRX PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 4568US8268862B2Sirtuin modulating compoundsBEMIS JEAN·Filed 2011·Granted Sep 18, 2012·1 cites·25 claims
- 4668US8217048B2Inhibitors of serine proteases, particularly HCV NS3-NS4A proteasePERNI ROBERT B·Filed 2010·Granted Jul 10, 2012·1 cites·38 claims
- 4768US2014056847A1Inhibitors of serine proteasesVERTEX PHARMA·Filed 2013·Application pending·0 cites
- 4867US11926574B2Dimethoxyphenylalkylamine activators of serotonin receptorsENTHEOGENIX BIOSCIENCES INC·Filed 2022·Granted Mar 12, 2024·0 cites·21 claims
- 4967US8187874B2Drug discovery methodPERNI ROBERT B·Filed 2004·Granted May 29, 2012·1 cites·16 claims
- 5067US2025152553A1Carbamothioate, and carbamodithioate derivatives of mdma, mda or its optically active (r)- or (s)-mdma and mda isomersEMPATHBIO INC·Filed 2024·Application pending·0 cites
Showing the top 50 of 108 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Robert B. Perni files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →